William Blair Upgrades 10x Genomics to Outperform

10x Genomics +1.17%

10x Genomics

TXG

23.27

+1.17%

William Blair analyst Matt Larew upgrades 10x Genomics (NASDAQ: TXG) from Market Perform to Outperform.